Home Tags Service approvals

Tag: service approvals

Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
BUSINESS News

Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges

HS -
0
First Pill for Postpartum Depression Is Approved by FDA
BUSINESS News

First Pill for Postpartum Depression Is Approved by FDA

HS -
0
Biogen Buying Rare-Disease Drugmaker in $7.3 Billion Deal
BUSINESS News

Biogen Buying Rare-Disease Drugmaker in $7.3 Billion Deal

HS -
0
FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients
BUSINESS News

FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients

HS -
0
Deadly Fungi Are Becoming More Common And We’re Running Out of Ways to Treat Them
BUSINESS News

Deadly Fungi Are Becoming More Common And We’re Running Out of Ways to Treat Them

HS -
0
FDA Allows Imports of China-Made Chemotherapy to Ease U.S. Shortage
BUSINESS News

FDA Allows Imports of China-Made Chemotherapy to Ease U.S. Shortage

HS -
0
FDA Approves GSK’s RSV Vaccine for Older Adults
BUSINESS News

FDA Approves GSK’s RSV Vaccine for Older Adults

HS -
0
Drug to Prevent Preterm Births to Be Pulled From Market
BUSINESS News

Drug to Prevent Preterm Births to Be Pulled From Market

HS -
0
Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults
BUSINESS News

Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults

HS -
0
New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients
BUSINESS News

New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients

HS -
0
Elon Musk Says Neuralink Should Be Ready for Human Testing in Six Months
BUSINESS News

Elon Musk Says Neuralink Should Be Ready for Human Testing in Six Months

HS -
0
Amylyx Prices Newly Approved ALS Drug at $12,500 a Month
BUSINESS News

Amylyx Prices Newly Approved ALS Drug at $12,500 a Month

HS -
0
Abbott Faces Competition From Heart Valve Device Cleared by FDA
BUSINESS News

Abbott Faces Competition From Heart Valve Device Cleared by FDA

HS -
0
Covid-19 Booster Shots Targeting Omicron Authorized, Likely to Be Offered Soon
BUSINESS News

Covid-19 Booster Shots Targeting Omicron Authorized, Likely to Be Offered Soon

HS -
0
U.K. Approves Covid-19 Booster Shot Aimed at Omicron
BUSINESS News

U.K. Approves Covid-19 Booster Shot Aimed at Omicron

HS -
0
Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics
BUSINESS News

Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics

HS -
0
Americans With ALS Look to Canada for Promising Drug the U.S. Hasn’t Approved
BUSINESS News

Americans With ALS Look to Canada for Promising Drug the U.S. Hasn’t Approved

HS -
0
© Newspaper WordPress Theme by TagDiv